UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies

Leukemia & lymphoma, 2018-03, Vol.59 (3), p.625-632

2018

Link zum Volltext

Verfügbarkeit prüfen

Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma

Leukemia & lymphoma, 2022-06, Vol.63 (7), p.1580-1588

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma

Leukemia & lymphoma, 2022-06, Vol.63 (7), p.1728-1732

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma

Leukemia & lymphoma, 2023-06, Vol.ahead-of-print (ahead-of-print), p.1-4

2023

Link zum Volltext

Verfügbarkeit prüfen

Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment

Leukemia & lymphoma, 2020-06, Vol.61 (7), p.1627-1635

2020

Link zum Volltext

Verfügbarkeit prüfen

Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Leukemia & lymphoma, 2021-11, Vol.62 (13), p.3278-3282

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation

Leukemia & lymphoma, 2019-12, Vol.60 (14), p.3569-3572

2019

Link zum Volltext

Verfügbarkeit prüfen

Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma

Leukemia & lymphoma, 2021-02, Vol.62 (3), p.598-605

2021

Link zum Volltext

Verfügbarkeit prüfen

Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)

Leukemia & lymphoma, 2020-06, Vol.61 (7), p.1636-1644

2020

Link zum Volltext

Verfügbarkeit prüfen

Infection in chronic lymphocytic leukemia: parsimony has its limits

Leukemia & lymphoma, 2014-12, Vol.55 (12), p.2683-2684

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Leukemia & lymphoma, 2016-03, Vol.57 (3), p.635-643

2016

Link zum Volltext

Verfügbarkeit prüfen

The ABC of chronic lymphocytic leukemia: Etiology of cytopenias is important in staging and management

Leukemia & lymphoma, 2014-06, Vol.55 (6), p.1219-1220

2014

Link zum Volltext

Verfügbarkeit prüfen

Getting to the heart of the problem in treating diffuse large B-cell lymphoma

Leukemia & lymphoma, 2011-07, Vol.52 (7), p.1166-1167

2011

Link zum Volltext

Verfügbarkeit prüfen

Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma

Leukemia & lymphoma, 2015-02, Vol.56 (2), p.508-511

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium

Leukemia & lymphoma, 2012-12, Vol.53 (12), p.2383-2389

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

PublikationsformBuchkapitel

Zeitschrift / SerieLeukemia & Lymphoma

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Kollektion

Taylor & Francis:Master (3349 titles)
(15)
Taylor & Francis Journals Auto-Holdings Collection
(15)
Taylor & Francis
(15)
MEDLINE
(11)

Menü

Weitere Dienste

Einstellungen

Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies

Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma

Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma

Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma

Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment

Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation

Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma

Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)

Infection in chronic lymphocytic leukemia: parsimony has its limits

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

The ABC of chronic lymphocytic leukemia: Etiology of cytopenias is important in staging and management

Getting to the heart of the problem in treating diffuse large B-cell lymphoma

Impact of dietary supplements, obesity and treatment initiation on serum vitamin D levels in patients with lymphoma

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium

Aktive Filter

Suchergebnisse filtern